JUNB and metastatic prostate carcinoma: Finally, a very interesting finding regarding JUNB’s presence and prognostic value was reported in 2024 by Roumeliotou et al., in which JUNB was detected in circulating tumor cells (CTCs) from metastatic prostate cancer cases, in a percentage as high as 28%, from a sample of 48 patients [95].